Skip to content

TAMedecin

Active
Private limited companyfounded 20241 yr activeAvenue des Sapins (N.) 29, 7020 Mons, BelgiumKBO/BCE: BE 1015.564.957
Summary

The computed 12-month bankruptcy probability of TAMedecin is 1.6% (moderate). The 2025 annual accounts show equity of €93,583 and a net result of €88,583. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes
Profitability100
Solvency76
Growth-
Track record67
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €7,000 at 30 days only on tighter terms
Liquidity ample (current ratio 3.04; short-term debt: 24.3% and cash: 70.4% of total assets), and 48.9% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
51.1%
Return on assets
48.4%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
11 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

TAMedecin was incorporated on 25 October 2024 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€93,583
Total assets
€183,121
Net result
€88,583
Working capital
€90,679

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €183,121
Fixed assets €47,921
Current assets €135,200
Equity and liabilities €183,121
Equity €93,583
Debt €89,538
Debt finances 48.9% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€113,984
Cash flow
€88,662
Current ratio
3.04
Debt to equity
0.96
ROE
94.7%
ROA
48.4%
Interest coverage
474.54
Debt ≤ 1 year
€44,521
Debt > 1 year
€39,017
Income taxes
€25,082

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

For this company itself Checked computes a higher bankruptcy probability: 1.6% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 35 lines
Balance sheet Code2025
Assets
Total assets20/58€183,121
Fixed assets21/28€47,921
Tangible fixed assets22/27€47,921
Furniture and vehicles24€47,921
Current assets29/58€135,200
Cash at bank and in hand54/58€128,893
Deferred charges and accrued income490/1€6,307
Equity and liabilities
Total equity and liabilities10/49€183,121
Equity10/15€93,583
Contributions10/11€5,000
Reserves13€88,583
Distributable reserves133€88,583
Amounts payable17/49€89,538
Amounts payable after more than one year17€39,017
Financial debts170/4€39,017
Amounts payable within one year42/48€44,521
Current portion of amounts payable after more than one year42€8,983
Trade debts44€10,456
Suppliers440/4€10,456
Taxes, remuneration and social security45€25,082
Taxes450/3€25,082
Accrued charges and deferred income492/3€6,000
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€79
Other operating charges640/8€898
Gross operating margin9900€114,882
Operating profit (loss)9901€113,905
Financial charges65/66B€240
Recurring financial charges65€240
Profit (loss) for the period before taxes9903€113,665
Income taxes67/77€25,082
Profit (loss) for the period9904€88,583
Profit (loss) for the period to be appropriated9905€88,583
Appropriation of the result
Profit (loss) to be appropriated9906€88,583
Transfer to equity691/2€88,583
To other reserves6921€88,583

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€79
Other operating charges640/8€898
Gross operating margin9900€114,882
Operating profit (loss)9901€113,905
Financial charges65/66B€240
Recurring financial charges65€240
Profit (loss) for the period before taxes9903€113,665
Income taxes67/77€25,082
Profit (loss) for the period9904€88,583
Profit (loss) for the period to be appropriated9905€88,583
Line2025
Assets
Total assets20/58€183,121
Fixed assets21/28€47,921
Tangible fixed assets22/27€47,921
Furniture and vehicles24€47,921
Current assets29/58€135,200
Cash at bank and in hand54/58€128,893
Deferred charges and accrued income490/1€6,307
Equity and liabilities
Total equity and liabilities10/49€183,121
Equity10/15€93,583
Contributions10/11€5,000
Reserves13€88,583
Distributable reserves133€88,583
Amounts payable17/49€89,538
Amounts payable after more than one year17€39,017
Financial debts170/4€39,017
Amounts payable within one year42/48€44,521
Current portion of amounts payable after more than one year42€8,983
Trade debts44€10,456
Suppliers440/4€10,456
Taxes, remuneration and social security45€25,082
Taxes450/3€25,082
Accrued charges and deferred income492/3€6,000
Line2025
Profit (loss) for the period9904€88,583
+ Depreciation and write-downs630€79
Operating cash flow (approximation)€88,662

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
20-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mons · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
9,546 m²
Building footprint
570 m²
Volume, LiDAR
3,435 m³
2 parcels, Wallonia · tallest building 15.5 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
TAMedecin
Rue Jacquet 10, 7061 SoigniesGeneral medical practice
since 20242.365.930.661
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
55044D0412/00K000 Wallonia 8,556 m² 1 · 316 m² 15.5 m · 4 fl.
53059A0248/00A019 Wallonia 990 m² 1 · 254 m² -
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded25-10-2024
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:1015564957
Registered 30-09-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.